3 years ago

Massively parallel de novo protein design for targeted therapeutics

Massively parallel de novo protein design for targeted therapeutics
James T. Fuller, Christopher D. Bahl, Cody M. Jenkins, Renan Vergara, Gabriel J. Rocklin, Deborah H. Fuller, Merika T. Koday, Lance Stewart, Daniel-Adriano Silva, Ian A. Wilson, Aaron Chevalier, Min Dong, Tom Colvin, Shin-Ichiro Miyashita, Derrick R. Hicks, Cassie M. Bryan, Kwok-Ho Lam, D. Alejandro Fernández-Velasco, Lu Zhang, Patience Murapa, Guorui Yao, Inna Goreshnik, Xuhui Huang, Alan Bohn, David Baker, Steffen M. Bernard, Rongsheng Jin, Lauren Carter
De novo protein design holds promise for creating small stable proteins with shapes customized to bind therapeutic targets. We describe a massively parallel approach for designing, manufacturing and screening mini-protein binders, integrating large-scale computational design, oligonucleotide synthesis, yeast display screening and next-generation sequencing. We designed and tested 22,660 mini-proteins of 37–43 residues that target influenza haemagglutinin and botulinum neurotoxin B, along with 6,286 control sequences to probe contributions to folding and binding, and identified 2,618 high-affinity binders. Comparison of the binding and non-binding design sets, which are two orders of magnitude larger than any previously investigated, enabled the evaluation and improvement of the computational model. Biophysical characterization of a subset of the binder designs showed that they are extremely stable and, unlike antibodies, do not lose activity after exposure to high temperatures. The designs elicit little or no immune response and provide potent prophylactic and therapeutic protection against influenza, even after extensive repeated dosing.

Publisher URL: http://dx.doi.org/10.1038/nature23912

DOI: 10.1038/nature23912

You might also like
Never Miss Important Research

Researcher is an app designed by academics, for academics. Create a personalised feed in two minutes.
Choose from over 15,000 academics journals covering ten research areas then let Researcher deliver you papers tailored to your interests each day.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.